Latest News

  • October 19, 2021

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Press Release

The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management® (PTM) platform. This will enable both parties…

  • October 12, 2021

Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies

Press Release

Together, Körber and Vineti will streamline process development, operations, and manufacturing to deliver advanced therapies to patients in need around…

  • August 13, 2021

Lykan and Vineti Form Cell Therapy Agreement

Publication: Contract Pharma

Partnership will streamline process development and manufacturing to deliver therapies to patients in need.

  • August 12, 2021

Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization

Press Release

Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will…

  • August 10, 2021

Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution

Press Release

Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients…

  • August 3, 2021

Uncharted Podcast #94, Democratizing healthcare and the importance of continuous learning with Amy DuRoss, CEO and Co-founder of Vineti by Uncharted Podcast

Publication: Uncharted Podcast

Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain…

  • July 15, 2021

PharmaVoice 100 Entrepreneurs

Publication: PharmaVoice 100

These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights.

  • May 28, 2021

Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies

Publication: Select Science

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…

  • May 26, 2021

Ori Biotech and Vineti collaborate on digital platform for CGTs

Publication: Manufacturing Chemist

Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).

Ori provides…

  • May 26, 2021

Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies

Press Release

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain.

  • May 10, 2021

Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution

Press Release

SAN FRANCISCO, May 10, 2021 (GLOBE NEWSWIRE) — Vineti, the developer of the leading digital platform of record for personalized therapeutics, today announced the release…

  • April 20, 2021

McKesson Ventures highlights investment priorities amidst a trail of successful exits

Publication: MedCity News

McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…